BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 17045197)

  • 1. Glucocorticoid action and the development of selective glucocorticoid receptor ligands.
    Cole TJ
    Biotechnol Annu Rev; 2006; 12():269-300. PubMed ID: 17045197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective glucocorticoid receptor ligands.
    Cole TJ; Mollard R
    Med Chem; 2007 Sep; 3(5):494-506. PubMed ID: 17897077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
    Schäcke H; Berger M; Rehwinkel H; Asadullah K
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug insight: selective agonists and antagonists of the glucocorticoid receptor.
    McMaster A; Ray DW
    Nat Clin Pract Endocrinol Metab; 2008 Feb; 4(2):91-101. PubMed ID: 18212811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.
    McMaster A; Ray DW
    Exp Physiol; 2007 Mar; 92(2):299-309. PubMed ID: 17138619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of glucocorticoids: beyond receptors.
    van der Laan S; Meijer OC
    Eur J Pharmacol; 2008 May; 585(2-3):483-91. PubMed ID: 18410913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pursuit of differentiated ligands for the glucocorticoid receptor.
    Coghlan MJ; Elmore SW; Kym PR; Kort ME
    Curr Top Med Chem; 2003; 3(14):1617-35. PubMed ID: 14683518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings.
    Haller J; Mikics E; Makara GB
    Front Neuroendocrinol; 2008 May; 29(2):273-91. PubMed ID: 18054070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system?
    De Bosscher K; Beck IM; Haegeman G
    Brain Behav Immun; 2010 Oct; 24(7):1035-42. PubMed ID: 20600811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
    Newton R; Holden NS
    Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index.
    Schäcke H; Rehwinkel H; Asadullah K; Cato AC
    Exp Dermatol; 2006 Aug; 15(8):565-73. PubMed ID: 16842594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical probes to identify the glucocorticoid receptor ligands in living cells.
    Awais M; Sato M; Umezawa Y
    Steroids; 2007 Dec; 72(14):949-54. PubMed ID: 17897691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Receptor mechanisms of glucocorticoid and antiglucocorticoid effects].
    Golikov PP
    Vopr Med Khim; 1996; 42(3):184-92. PubMed ID: 9139449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists.
    Stahn C; Löwenberg M; Hommes DW; Buttgereit F
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):71-8. PubMed ID: 17630118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
    Löwenberg M; Stahn C; Hommes DW; Buttgereit F
    Steroids; 2008 Oct; 73(9-10):1025-9. PubMed ID: 18221974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential in vivo effects on target pathways of a novel arylpyrazole glucocorticoid receptor modulator compared with prednisolone.
    Roohk DJ; Varady KA; Turner SM; Emson CL; Gelling RW; Shankaran M; Lindwall G; Shipp LE; Scanlan TS; Wang JC; Hellerstein MK
    J Pharmacol Exp Ther; 2010 Apr; 333(1):281-9. PubMed ID: 20065017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids, metabolism and metabolic diseases.
    Vegiopoulos A; Herzig S
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):43-61. PubMed ID: 17624658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting inflammation using selective glucocorticoid receptor modulators.
    De Bosscher K; Haegeman G; Elewaut D
    Curr Opin Pharmacol; 2010 Aug; 10(4):497-504. PubMed ID: 20493772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of calpains in ligand-induced degradation of the glucocorticoid receptor.
    Kim YS; Kim J; Kim Y; Lee YH; Kim JH; Lee SJ; Shin SY; Ko J
    Biochem Biophys Res Commun; 2008 Sep; 374(2):373-7. PubMed ID: 18640094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociated glucocorticoid receptor ligands.
    Schäcke H; Rehwinkel H
    Curr Opin Investig Drugs; 2004 May; 5(5):524-8. PubMed ID: 15202726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.